Volume 22, Issue 12, Pages (December 2015)

Slides:



Advertisements
Similar presentations
Matthew D. Disney, Peter H. Seeberger  Chemistry & Biology 
Advertisements

Volume 19, Issue 2, Pages (February 2012)
Volume 12, Issue 1, Pages (January 2005)
Volume 24, Issue 8, Pages e5 (August 2017)
Adding Specificity to Artificial Transcription Activators
Thomas E. Edwards, Bruce H. Robinson, Snorri Th. Sigurdsson 
Volume 20, Issue 14, Pages (July 2010)
Volume 19, Issue 2, Pages (January 2009)
Structure of the Papillomavirus DNA-Tethering Complex E2:Brd4 and a Peptide that Ablates HPV Chromosomal Association  Eric A. Abbate, Christian Voitenleitner,
An Intersubunit Interaction Regulates Trafficking of Rod Cyclic Nucleotide-Gated Channels and Is Disrupted in an Inherited Form of Blindness  Matthew.
Volume 25, Issue 24, Pages (December 2015)
Volume 21, Issue 4, Pages (April 2014)
Volume 23, Issue 20, Pages (October 2013)
Biofilm Inhibitors that Target Amyloid Proteins
Volume 21, Issue 1, Pages (January 2011)
Volume 22, Issue 3, Pages (March 2015)
Adaptive Assembly: Maximizing the Potential of a Given Functional Peptide with a Tailor-Made Protein Scaffold  Hideki Watanabe, Shinya Honda  Chemistry.
No Need To Be Pure: Mix the Cultures!
Rasmus D. Jahnsen, Evan F. Haney, Henrik Franzyk, Robert E.W. Hancock 
Volume 14, Issue 10, Pages (October 2007)
Volume 23, Issue 8, Pages (August 2016)
Beena Krishnan, Lila M. Gierasch  Chemistry & Biology 
Volume 25, Issue 1, Pages e6 (January 2018)
Volume 21, Issue 2, Pages (February 2014)
A Gating Mechanism of the Serotonin 5-HT3 Receptor
Volume 19, Issue 2, Pages (February 2012)
Volume 22, Issue 1, Pages (January 2015)
Volume 19, Issue 19, Pages (October 2009)
Volume 15, Issue 1, Pages 5-11 (January 2008)
Volume 14, Issue 9, Pages (September 2007)
Volume 20, Issue 1, Pages (January 2013)
Volume 12, Issue 1, Pages (January 2005)
Sharona E Gordon, Michael D Varnum, William N Zagotta  Neuron 
Volume 76, Issue 3, Pages (November 2012)
Volume 22, Issue 1, Pages (January 2015)
Volume 18, Issue 4, Pages (April 2011)
Volume 24, Issue 12, Pages e5 (December 2017)
Volume 25, Issue 1, Pages e3 (January 2018)
Volume 16, Issue 6, Pages (June 2009)
Volume 11, Issue 1, Pages (January 2004)
Volume 22, Issue 2, Pages (February 2015)
Protein Misfolded Oligomers: Experimental Approaches, Mechanism of Formation, and Structure-Toxicity Relationships  Francesco Bemporad, Fabrizio Chiti 
Volume 20, Issue 8, Pages (August 2013)
Volume 15, Issue 10, Pages (June 2016)
Direct Activation of Epac by Sulfonylurea Is Isoform Selective
Volume 19, Issue 2, Pages (January 2009)
Volume 22, Issue 14, Pages (July 2012)
Profiling the Sulfation Specificities of Glycosaminoglycan Interactions with Growth Factors and Chemotactic Proteins Using Microarrays  Eric L. Shipp,
Protein Kinase D Inhibitors Uncouple Phosphorylation from Activity by Promoting Agonist-Dependent Activation Loop Phosphorylation  Maya T. Kunkel, Alexandra C.
Kari Barlan, Wen Lu, Vladimir I. Gelfand  Current Biology 
Volume 15, Issue 12, Pages (December 2007)
Volume 22, Issue 14, Pages (July 2012)
Volume 21, Issue 4, Pages (February 2011)
Volume 21, Issue 10, Pages (October 2014)
Volume 21, Issue 7, Pages (July 2014)
Damien Thévenin, Ming An, Donald M. Engelman  Chemistry & Biology 
Volume 18, Issue 12, Pages (December 2011)
Volume 123, Issue 1, Pages (July 2002)
Volume 18, Issue 3, Pages (March 2011)
Structural Biology: Piezo Senses Tension through Curvature
Matthew D. Disney, Peter H. Seeberger  Chemistry & Biology 
Volume 15, Issue 24, Pages (December 2005)
Volume 28, Issue 3, Pages e4 (February 2018)
Volume 22, Issue 1, Pages (January 2015)
Volume 22, Issue 11, Pages (November 2015)
Volume 23, Issue 3, Pages (March 2016)
Volume 36, Issue 4, Pages (November 2009)
Volume 18, Issue 8, Pages (August 2011)
Irene Iscla, Gal Levin, Robin Wray, Robert Reynolds, Paul Blount 
Volume 15, Issue 12, Pages (December 2007)
Presentation transcript:

Volume 22, Issue 12, Pages 1653-1661 (December 2015) Synthetic Peptides as cGMP-Independent Activators of cGMP-Dependent Protein Kinase Iα  Thomas M. Moon, Nathan R. Tykocki, Jessica L. Sheehe, Brent W. Osborne, Werner Tegge, Joseph E. Brayden, Wolfgang R. Dostmann  Chemistry & Biology  Volume 22, Issue 12, Pages 1653-1661 (December 2015) DOI: 10.1016/j.chembiol.2015.11.005 Copyright © 2015 Elsevier Ltd Terms and Conditions

Chemistry & Biology 2015 22, 1653-1661DOI: (10. 1016/j. chembiol. 2015 Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 1 Structure of the cGMP Binding Sites from the Regulatory Domain of PKG Iα (A) Emphasis is given to the asymmetric interaction of helical segments between the cGMP binding sites (denoted B and B′) on opposing protomers of PKG Iα (PDB: 3SHR). Also shown are the switch helix domains (SW and SW′) from each protomer. (B) Directional view, indicated by arrow in (A), detailing the interaction of the knob residues (F350′, F351′, L354′) with the nest (N353′; not depicted). (C) Electrostatic surface representation of the cGMP B-site demonstrating its amino acid composition, the boundaries of the nest, and its location relative to the cGMP- binding site. The dashed line represents the demarcation of the regions of the nest and the cGMP-binding site within the B domain. Chemistry & Biology 2015 22, 1653-1661DOI: (10.1016/j.chembiol.2015.11.005) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 2 Activation of PKG Iα by S-Tides (A and B) Activity of PKG Iα was measured using peptides with (A) C-terminal truncation modifications and (B) N-terminal truncation mutants derived from the parent compound S1.1. Activity is expressed as a percentage relative to 5 μM cGMP for individual experiments. Values indicated are the mean ± SD. (C and D) Secondary structure determination of (C) C-terminal and (D) N-terminal truncation mutants as measured by CD spectroscopy. Mean residue ellipticity (θ) is expressed as mdeg × cm2/dmol × residue. Chemistry & Biology 2015 22, 1653-1661DOI: (10.1016/j.chembiol.2015.11.005) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 3 Effects of Peptide- or cGMP-Treated PKG Iα Added to the Cytosolic Face of Excised, Inside-Out Membrane Patches Containing KCa1.1 Channels (A) Representative control (left) and experimental traces (right) of single KCa1.1 channel openings in excised membrane patches from cerebral artery myocytes. (B) The combined results of single KCa1.1 recordings demonstrate a substantially increased NPo versus control for saturating cGMP levels and S-tides S1.1 and S1.5 (†p < 0.002, ∗p < 0.05). Mean values with SEM are represented. Dashed line indicates normalized channel activity from control patches. Chemistry & Biology 2015 22, 1653-1661DOI: (10.1016/j.chembiol.2015.11.005) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 4 Intracellular Delivery of S-Tides by Reverse Permeablization Posterior cerebral arteries were subjected to reverse permeabilization with FITC-βAla2-S1.5 (experimental, left panel) and S1.5 (control, right panel) peptides. Following digestion using papain and collagenase, single smooth muscle cells were imaged using differential interference contrast microscopy (DIC) and confocal fluorescence microscopy. Chemistry & Biology 2015 22, 1653-1661DOI: (10.1016/j.chembiol.2015.11.005) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 5 S-Tides Cause BK Channel-Dependent Inhibition of Myogenic Tone Development in Posterior Cerebral Arteries (A) Diameter measurements for endothelium-denuded, reversibly permeabilized arteries demonstrating myogenic tone response in (Aa) control and (Ab) S1.5-treated arteries. (Ac–Ae) Summarized results of diameter measurements for endothelium-denuded arteries in control and permeabilized treatments are shown with values represented as the mean ± SEM. Differences in myogenic tone in response to pressure (Ac) as well as paxilline-induced constriction (Ad) are shown (∗p < 0.05). (B) Diameter measurements from endothelium-intact arteries for controls (Ba) and S1.5-treated arteries (Bb) show unaltered myogenic tone response (Bc) but small differences in paxilline-induced constriction of control and S1.5-treated arteries (Bd, ∗p < 0.02). For both sets of experiments, total constriction (Ae, Be) was unchanged between controls and S1.5-treated arteries. Chemistry & Biology 2015 22, 1653-1661DOI: (10.1016/j.chembiol.2015.11.005) Copyright © 2015 Elsevier Ltd Terms and Conditions